Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
09-11 June, 2025
Annual Outsourcing in ...Annual Outsourcing in CT
Not Confirmed
Not Confirmed
10-11 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
09-11 June, 2025
Annual Outsourcing in ...Annual Outsourcing in CT
Industry Trade Show
Not Confirmed
10-11 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
08 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/nektar-therapeutics-reports-first-quarter-2025-financial-results-302450173.html
24 Feb 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/nektar-announces-clinical-trial-agreement-to-evaluate-rezpegaldesleukin-in-patients-with-new-onset-type-1-diabetes-mellitus-302383052.html
10 Feb 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/nektar-therapeutics-receives-fast-track-designation-for-rezpegaldesleukin-for-the-treatment-of-moderate-to-severe-atopic-dermatitis-302371995.html
02 Dec 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/ampersand-capital-partners-completes-acquisition-of-nektar-therapeutics-peg-reagent-manufacturing-business-launching-newly-branded-gannet-biochem-302319679.html
18 Nov 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/nektar-therapeutics-presents-first-preclinical-data-from-novel-csf-1-program-nktr-422-at-2024-american-college-of-rheumatology-acr-convergence-302307672.html
07 Nov 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/nektar-and-collaborators-present-late-breaking-results-from-phase-2-study-of-nktr-255-for-the-treatment-of-radiation-induced-lymphopenia-in-locally-advanced-non-small-cell-lung-cancer-patients-at-society-for-immunotherapy-of-cance-302298158.html
Excipients
Inspections and registrations
ABOUT THIS PAGE
Nektar Therapeutics is a supplier offers 6 products (APIs, Excipients or Intermediates).
Find a price of NKTR-255 DRUG PRODUCT bulk with DMF offered by Nektar Therapeutics
Find a price of NKTR-255 DRUG SUBSTANCE bulk with DMF offered by Nektar Therapeutics
Find a price of Amikacin bulk offered by Nektar Therapeutics
Find a price of Lysine bulk offered by Nektar Therapeutics
Find a price of Macrogol bulk offered by Nektar Therapeutics
Find a price of PEG2MAL40K bulk offered by Nektar Therapeutics